Previous Close | 185.20 |
Open | 186.00 |
Bid | 183.40 x 391200 |
Ask | 183.60 x 721000 |
Day's Range | 182.00 - 189.00 |
52 Week Range | 154.60 - 209.50 |
Volume | |
Avg. Volume | 66,869 |
Market Cap | 18.154B |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | 22.33 |
EPS (TTM) | 8.15 |
Earnings Date | Jan 29, 2025 |
Forward Dividend & Yield | 3.75 (2.02%) |
Ex-Dividend Date | Apr 12, 2024 |
1y Target Est | 215.50 |
Borregaard ASA (FRA:BO4) reports robust growth in EBITDA and operating revenues, driven by increased sales volumes and strategic investments.
Borregaard’s operating revenues were NOK 1,949 million (NOK 1,714 million)2 in the 3rd quarter of 2024. EBITDA1 reached NOK 524 million (NOK 482 million). The result in both BioSolutions and Fine Chemicals increased while the result in BioMaterials was lower compared with the 3rd quarter of 2023. Increased sales volume was the main reason for the improved result in BioSolutions. For BioMaterials, significantly higher deliveries were more than offset by increased wood costs and other operating ex